piracetam has been researched along with Cerebral Amyloid Angiopathy in 1 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Cerebral Amyloid Angiopathy: A heterogeneous group of sporadic or familial disorders characterized by AMYLOID deposits in the walls of small and medium sized blood vessels of CEREBRAL CORTEX and MENINGES. Clinical features include multiple, small lobar CEREBRAL HEMORRHAGE; cerebral ischemia (BRAIN ISCHEMIA); and CEREBRAL INFARCTION. Cerebral amyloid angiopathy is unrelated to generalized AMYLOIDOSIS. Amyloidogenic peptides in this condition are nearly always the same ones found in ALZHEIMER DISEASE. (from Kumar: Robbins and Cotran: Pathologic Basis of Disease, 7th ed., 2005)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| García Estévez, DA | 1 |
| García-Dorrego, RM | 1 |
| Nieto-Baltar, B | 1 |
| Marey-Garrido, M | 1 |
| Hierro-Torner, T | 1 |
1 other study available for piracetam and Cerebral Amyloid Angiopathy
| Article | Year |
|---|---|
Spontaneous convexity subarachnoid haemorrhage: Clinical series of 3 patients with associated cerebral amyloid angiopathy.
Topics: Aged; Anticonvulsants; Brain; Cerebral Amyloid Angiopathy; Dexamethasone; Female; Glucocorticoids; H | 2017 |